Skip to Main Content

Author Details

Renee C Ireton
Center for Innate Immunity and Immune Disease, University of Washington
1997
32
19
PMIDPaper TitleJournal TitlePublished Year
36939421A Small Molecule RIG-I Agonist Serves as an Adjuvant to Induce Broad Multifaceted Influenza Virus Vaccine Immunity.J Immunol2023
37466213Viral Resistance Analyses From the Remdesivir Phase 3 Adaptive COVID-19 Treatment Trial-1 (ACTT-1).J Infect Dis2023
36851745Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron.Viruses2023
36913789Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study.J Clin Virol2023
36705692Albert Reynolds (1956-2022): The father of p120.J Cell Biol2023
36032965Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron.medRxiv2022
30371803Immune Correlates of Protection From West Nile Virus Neuroinvasion and Disease.J Infect Dis2019
29982912Interferon-stimulated genes: new platforms and computational approaches.Mamm Genome2018
28592649Oas1b-dependent Immune Transcriptional Profiles of West Nile Virus Infection in the Collaborative Cross.G3 (Bethesda)2017
28279563A small-molecule IRF3 agonist functions as an influenza vaccine adjuvant by modulating the antiviral immune response.Vaccine2017
28808965RNA PAMPs as Molecular Tools for Evaluating RIG-I Function in Innate Immunity.Methods Mol Biol2017
27806117A Mouse Model of Chronic West Nile Virus Disease.PLoS Pathog2016
27872814Transcriptional profiles of WNV neurovirulence in a genetically diverse Collaborative Cross population.Genom Data2016
27843766Identifying protective host gene expression signatures within the spleen during West Nile virus infection in the collaborative cross model.Genom Data2016
25944860Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes.mBio2015
26676770Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.J Virol2015
24907428Pushing to a cure by harnessing innate immunity against hepatitis C virus.Antiviral Res2014
22903567Systems biology analyses to define host responses to HCV infection and therapy.Curr Top Microbiol Immunol2013
21994761RIG-I like receptors in antiviral immunity and therapeutic applications.Viruses2011
19936259Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.PLoS One2009
18198190Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism.J Cell Sci2008
18560578Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.PLoS One2008
18547137A mouse to human search for plasma proteome changes associated with pancreatic tumor development.PLoS Med2008
15892616EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics.Curr Cancer Drug Targets2005
14610055A core function for p120-catenin in cadherin turnover.J Cell Biol2003
12427869A novel role for p120 catenin in E-cadherin function.J Cell Biol2002
11461664Monoclonal antibodies to Kaiso: a novel transcription factor and p120ctn-binding protein.Hybridoma2001
10629228Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion.J Cell Biol2000
11081392Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation.Bone Marrow Transplant2000
9973112Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease.Prostate1999
9650914Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides.Prostate1998
9288186Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides.Prostate1997
  • 1 - 32 of 32

Recommended Authors

Mehdi Bouhaddou
J. David Gladstone Institutes
Career Start Year 2014
Number of shared co-authors 2
Aaron L Oom
New York University Grossman School of Medicine
Career Start Year 2014
Number of shared co-authors 1
Ang Cui
Massachusetts Institute of Technology
Career Start Year 2013
Number of shared co-authors 0
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 1
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 4
Ragunath Singaravelu
Ottawa Hospital Research Institute
Career Start Year 2010
Number of shared co-authors 0
Jianying Zhang
City of Hope National Medical Center
Career Start Year 2009
Number of shared co-authors 0
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 2
Carolina S Ilkow
Ottawa Hospital Research Institute
Career Start Year 2006
Number of shared co-authors 0
Stephanie A Montgomery
and Lineberger Comprehensive Cancer Center, University of North Carolina System
Career Start Year 2006
Number of shared co-authors 8
Maggie Cam
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2005
Number of shared co-authors 0
Agnes C Paquet
Universite Cote d'Azur, CNRS UMR5
Career Start Year 2004
Number of shared co-authors 0
Aleksandra A Pandyra
Hematology and Clinical Immunology, Heinrich-Heine University Dusseldorf
Career Start Year 2003
Number of shared co-authors 0
Paul D De Jesus
Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2003
Number of shared co-authors 1
Andrew V Kossenkov
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 1
Travis R Taylor
University of Toledo
Career Start Year 2002
Number of shared co-authors 1
Shirit Einav
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 1
Sean C Proll
Fred Hutchinson Cancer Research Center
Career Start Year 2001
Number of shared co-authors 12
Sumit K Chanda
The Scripps Research Institute
Career Start Year 2001
Number of shared co-authors 2
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Priya Ranjan
Pondicherry University
Career Start Year 1997
Number of shared co-authors 2
Robert H Carnahan
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 1
Sangdun Choi
Ajou University
Career Start Year 1995
Number of shared co-authors 0
Jenny Xiang
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 1993
Number of shared co-authors 0
Melanie Ott
Gladstone Institute of Virology
Career Start Year 1993
Number of shared co-authors 3
Zhiqiang An
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 1
Garry P Nolan
Stanford University School of Medicine
Career Start Year 1985
Number of shared co-authors 2
Richard H Scheuermann
J. Craig Venter Institute
Career Start Year 1983
Number of shared co-authors 8
Judy Lieberman
Boston Children's Hospital
Career Start Year 1978
Number of shared co-authors 0

Collaborators

Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 17
Courtney Wilkins
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 7
Richard Green
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 7
Sunil Thomas
Lankenau Institute for Medical Research
Co-authored papers 6
Aimee Sekine
Center for Innate Immunity and Immune Disease
Co-authored papers 5
Kathleen M Voss
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 5
Martin T Ferris
University of North Carolina.
Co-authored papers 5
Fernando Pardo-Manuel de Villena
University of North Carolina
Co-authored papers 4
Ralph S Baric
University of North Carolina
Co-authored papers 4
Alexander L Greninger
University of Washington Medical Center
Co-authored papers 4
Duncan Hendrick
University of Washington
Co-authored papers 3
Jennifer M Lund
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Qing Zhang
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Co-authored papers 3
Jessica B Graham
BIO5 Institute, The University of Arizona
Co-authored papers 3
Samir M Hanash
University of Texas MD Anderson Cancer Center
Co-authored papers 3
Sharon J Pitteri
Stanford University
Co-authored papers 3
Jessica L Swarts
Fred Hutchinson Cancer Research Center
Co-authored papers 3
Wesley C Van Voorhis
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Co-authored papers 2
Gabrielle Choonoo
Regeneron Pharmaceuticals
Co-authored papers 2
Anna Wald
University of Washington School of Medicine
Co-authored papers 2
Shannon K McWeeney
Oregon Health & Science University, University of California Berkeley
Co-authored papers 2
Piper M Treuting
University of Washington
Co-authored papers 2
Michael A Mooney
Knight Cancer Institute Oregon Health & Science University Portland Oregon USA.
Co-authored papers 2
Mark T Heise
University of North Carolina at Chapel Hill.
Co-authored papers 2
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Co-authored papers 1
Nabeel Bardeesy
Massachusetts General Hospital
Co-authored papers 1
Darla R Miller
The University of North Carolina at Chapel Hill
Co-authored papers 1
Keith R Jerome
Fred Hutchinson Cancer Center
Co-authored papers 1
Shari M Kaiser
Seattle Biomedical Research Institute
Co-authored papers 1
Mehul S Suthar
Co-authored papers 1
Release 1.2